India's Alkem Laboratories falls after quarterly profit miss
** Shares of Alkem Laboratories ALKE.NS drop 7.9% to 5,407 rupees ** Pharmaceuticals co's Q3 consol profit at 6.36 bln rupees ($70.1 mln), missing estimates of 6.51 bln rupees, as per data compiled by LSEG ** Q3 consol revenue at 37.37 bln rupees also missed estimates of 37.6 bln rupees ** Trading vols over 4x the 30-day average at 468,275 shares so far ** ALKE fell ~2% in 2025 ($1 = 90.6890 Indian rupees) (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees